Company Press Releases Kathleen Otto 5/16/24 Kathleen Otto 5/16/24 NemaLife Launches AI-Powered Platform for Comprehensive Nutritional Bioactive Screening Read More Kathleen Otto 5/15/24 Kathleen Otto 5/15/24 CPRIT Names Kristen Doyle as New CEO, Continuing Legacy of Leadership Read More Kathleen Otto 5/15/24 Kathleen Otto 5/15/24 CPRIT Announces $52M in Grants to Propel Cancer Research in Texas Read More Kathleen Otto 5/14/24 Kathleen Otto 5/14/24 Etira Advances Oncology Breakthrough: ERX-315 Regulatory Submission Marks Milestone Read More Kathleen Otto 5/9/24 Kathleen Otto 5/9/24 JPS Health Network Joins United Way Initiative to Improve Maternal Health Read More Kathleen Otto 5/8/24 Kathleen Otto 5/8/24 Colossal Biosciences and University of Melbourne Make Breakthrough in Saving Endangered Northern Quoll Read More Kathleen Otto 5/8/24 Kathleen Otto 5/8/24 Island Pharmaceuticals Advances Dengue Trial with Grant Reassignment Read More Kathleen Otto 5/7/24 Kathleen Otto 5/7/24 Transforming Health Equity: The VOICES of Black Women® Study by the American Cancer Society Read More Kathleen Otto 5/7/24 Kathleen Otto 5/7/24 RxLink Partners with Cost Plus Drugs to Deliver Affordable Medications to Patients Read More Kathleen Otto 5/6/24 Kathleen Otto 5/6/24 Lantern Pharma and Oregon Therapeutics Join Forces to Optimize XCE853 for Drug-Resistant Cancer Read More Kathleen Otto 5/3/24 Kathleen Otto 5/3/24 JPS Collaborates with Hear Fort Worth for Sound Care Program, Offering Affordable Healthcare to Tarrant County Musicians and Industry Workers Read More Kathleen Otto 5/3/24 Kathleen Otto 5/3/24 Johnson & Johnson Presents Positive Results from ERLEADA® Phase 2 Study for High-Risk Localized Prostate Cancer Post-Radical Prostatectomy Read More Kathleen Otto 5/1/24 Kathleen Otto 5/1/24 ACS Releases Report on Cancer Disparities in AANHPI Communities Read More Kathleen Otto 5/1/24 Kathleen Otto 5/1/24 Janssen-Cilag Seeks EMA Approval for Guselkumab in Ulcerative Colitis and Crohn’s Disease Read More Kathleen Otto 4/29/24 Kathleen Otto 4/29/24 Ernst & Young Poll Reveals AI's Impact on Future of Work Read More Kathleen Otto 4/29/24 Kathleen Otto 4/29/24 Dallas College Advances to Final Round of Community College Innovation Challenge with AMBER Project Read More Kathleen Otto 4/26/24 Kathleen Otto 4/26/24 Janssen-Cilag, a Johnson & Johnson company, Receives CHMP Nod for RYBREVANT® in First-Line NSCLC Treatment with EGFR Exon 20 Insertion Mutations Read More Kathleen Otto 4/26/24 Kathleen Otto 4/26/24 Member of Congress ‘flies out’ to Nanoscope Therapeutics Read More Kathleen Otto 4/26/24 Kathleen Otto 4/26/24 Medtronic's Inceptiv™ Closed-Loop Spinal Cord Stimulator Receives FDA Approval for Chronic Pain Treatment Read More Kathleen Otto 4/26/24 Kathleen Otto 4/26/24 McKesson Chosen as Specialty Pharmacy for OJEMDATM for Pediatric Low-Grade Glioma Treatment Read More Older Posts
Kathleen Otto 5/16/24 Kathleen Otto 5/16/24 NemaLife Launches AI-Powered Platform for Comprehensive Nutritional Bioactive Screening Read More
Kathleen Otto 5/15/24 Kathleen Otto 5/15/24 CPRIT Names Kristen Doyle as New CEO, Continuing Legacy of Leadership Read More
Kathleen Otto 5/15/24 Kathleen Otto 5/15/24 CPRIT Announces $52M in Grants to Propel Cancer Research in Texas Read More
Kathleen Otto 5/14/24 Kathleen Otto 5/14/24 Etira Advances Oncology Breakthrough: ERX-315 Regulatory Submission Marks Milestone Read More
Kathleen Otto 5/9/24 Kathleen Otto 5/9/24 JPS Health Network Joins United Way Initiative to Improve Maternal Health Read More
Kathleen Otto 5/8/24 Kathleen Otto 5/8/24 Colossal Biosciences and University of Melbourne Make Breakthrough in Saving Endangered Northern Quoll Read More
Kathleen Otto 5/8/24 Kathleen Otto 5/8/24 Island Pharmaceuticals Advances Dengue Trial with Grant Reassignment Read More
Kathleen Otto 5/7/24 Kathleen Otto 5/7/24 Transforming Health Equity: The VOICES of Black Women® Study by the American Cancer Society Read More
Kathleen Otto 5/7/24 Kathleen Otto 5/7/24 RxLink Partners with Cost Plus Drugs to Deliver Affordable Medications to Patients Read More
Kathleen Otto 5/6/24 Kathleen Otto 5/6/24 Lantern Pharma and Oregon Therapeutics Join Forces to Optimize XCE853 for Drug-Resistant Cancer Read More
Kathleen Otto 5/3/24 Kathleen Otto 5/3/24 JPS Collaborates with Hear Fort Worth for Sound Care Program, Offering Affordable Healthcare to Tarrant County Musicians and Industry Workers Read More
Kathleen Otto 5/3/24 Kathleen Otto 5/3/24 Johnson & Johnson Presents Positive Results from ERLEADA® Phase 2 Study for High-Risk Localized Prostate Cancer Post-Radical Prostatectomy Read More
Kathleen Otto 5/1/24 Kathleen Otto 5/1/24 ACS Releases Report on Cancer Disparities in AANHPI Communities Read More
Kathleen Otto 5/1/24 Kathleen Otto 5/1/24 Janssen-Cilag Seeks EMA Approval for Guselkumab in Ulcerative Colitis and Crohn’s Disease Read More
Kathleen Otto 4/29/24 Kathleen Otto 4/29/24 Ernst & Young Poll Reveals AI's Impact on Future of Work Read More
Kathleen Otto 4/29/24 Kathleen Otto 4/29/24 Dallas College Advances to Final Round of Community College Innovation Challenge with AMBER Project Read More
Kathleen Otto 4/26/24 Kathleen Otto 4/26/24 Janssen-Cilag, a Johnson & Johnson company, Receives CHMP Nod for RYBREVANT® in First-Line NSCLC Treatment with EGFR Exon 20 Insertion Mutations Read More
Kathleen Otto 4/26/24 Kathleen Otto 4/26/24 Member of Congress ‘flies out’ to Nanoscope Therapeutics Read More
Kathleen Otto 4/26/24 Kathleen Otto 4/26/24 Medtronic's Inceptiv™ Closed-Loop Spinal Cord Stimulator Receives FDA Approval for Chronic Pain Treatment Read More
Kathleen Otto 4/26/24 Kathleen Otto 4/26/24 McKesson Chosen as Specialty Pharmacy for OJEMDATM for Pediatric Low-Grade Glioma Treatment Read More
